Organizational Chart

Kåre Schultz

President & CEO

Nir Baron

EVP, Chief Internal Auditor

Dr. Michael Hayden

President of Global R&D and Chief Scientific Officer

Dipankar Bhattacharjee

President & CEO Global Generic Medicines

Dr. Rob Koremans

President & CEO Global Specialty Medicines

Dr. Carlo de Notaristefani

President & CEO Global Operations

David M. Stark

Group Executive Vice President, Chief Legal Officer

Mike McClellan

Senior Vice President, Interim Chief Financial Officer

Mark Sabag

Group EVP, Chief Human Resources Officer

Iris Beck-Codner

Group Executive Vice President, Corporate Marketing Excellence and Communication Corporate Marketing Excellence and Communication

Dr. Hafrun Fridriksdottir

Executive Vice President, President of Global Generics R&D